icon-folder.gif   Conference Reports for NATAP  
 
  The Liver Meeting
Digital Experience
AASLD
Washington on 04-08
November 2022
Back grey_arrow_rt.gif
 
 
 
Compassionate use of subcutaneously administered
REP 2139-Mg in cirrhotic HBV / HDV co-infection

 
 
  AASLD 2022 Nov 4-8
 
Marc Bourliere1, Veronique Loustaud-Ratti2, Christiane Stern3, Michel Bazinet4, Souad Ben Ali1, Laurence Lecomte1, Sandrine Francois2, Cecilia de Freitas3, Athena´s Gerber5, Segolene Brichler5, Emmanuel Gordien5, Andrew Vaillant
 
1. Service Hepato-Gastro-Enterologie, Hopital Saint-Joseph, Marseille, France, 2. Department Hepatogastroenterology, Centre hospitalier universitaire a Limoges, Limoges, France, 3. Department de Hepatologie, AP-HP Hopital Beaujon, Clichy, France 4. Replicor Inc. Montreal, Canada, 5. Centre national de reference des hepatite B, C et Delta - Laboratoire associe, Hopital Avicenne, Bobigny, France

1114221

1114222

1114223

1114224

1114225

1114226

1114227

1114228

1114229

11142210

11142211